SAN DIEGO–(BUSINESS WIRE)–$MXL #MaxLinearInc—Robbins LLP reminds investors of a class action lawsuit against MaxLinear, Inc….
Co-Founder and CEO Kiwi Camara has stepped down from the company Experienced business executive Scott…
RADNOR, Pa.–(BUSINESS WIRE)–Lincoln Financial Group (NYSE: LNC) today announced the election of Owen Ryan as…
VALLEY FORGE, Pa.–(BUSINESS WIRE)–#BoardOfDirectors–UGI Corporation (NYSE: UGI) announced today that Santiago Seage was elected a…
The new natural language interface, now in private preview, delivers the ease of use required…
Information concerning the total number of voting rights and shares, provided pursuant to article L….
Company Renamed “Spectral AI, Ltd.” and Will Commence Trading on Nasdaq Global Market Under the…
Complete topline results confirm treatment was well tolerated, with promising clinical activity of pathologic complete…
Planegg/Martinsried, September 11, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an…
EDMONTON, Alberta, Sept. 11, 2023 (GLOBE NEWSWIRE) — Grant Dakin, owner and founder of Solid…
Lower prices offer added savings on top medications for heart disease, men’s health, mental health…
Modern approach enables collaboration between business users and IT teams to meet the growing needs…
NEW YORK–(BUSINESS WIRE)–Leading digital finance innovator Zip Co (ASX: ZIP) has announced a strategic partnership…
DALLAS–(BUSINESS WIRE)–Continuing a rich history globally, spanning over a decade, Suprema America and BioConnect have…
Anticipate completion of Phase 1 & Phase 2 clinical trials in chronic pruritis over the…
Anticipate completion of Phase 1 & Phase 2 clinical trials in chronic pruritis over the…
XI’AN, China, Sept. 11, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
XI’AN, China, Sept. 11, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
MONMOUTH JUNCTION, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) — Elucida Oncology, a clinical-stage biotechnology company…
MONMOUTH JUNCTION, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) — Elucida Oncology, a clinical-stage biotechnology company…